Enterococcal isolates carrying the novel oxazolidinone resistance gene optrA from hospitals in Zhejiang, Guangdong, and Henan, China, 2010-2014

被引:80
作者
Cai, J. [1 ]
Wang, Y. [2 ]
Schwarz, S. [3 ]
Lv, H. [4 ]
Li, Y. [5 ]
Liao, K. [6 ]
Yu, S. [7 ]
Zhao, K. [8 ]
Gu, D. [1 ]
Wang, X. [1 ]
Zhang, R. [1 ]
Shen, J. [2 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Clin Microbiol Lab, Hangzhou 310003, Zhejiang, Peoples R China
[2] China Agr Univ, Coll Vet Med, Dept Vet Pharmacol, Beijing 100193, Peoples R China
[3] FLI, Inst Farm Anim Genet, Neustadt, Germany
[4] Zhejiang Prov Peoples Hosp, Hangzhou, Zhejiang, Peoples R China
[5] Henan Prov Peoples Hosp, Zhengzhou, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China
[7] Taizhou Hosp, Taizhou, Peoples R China
[8] Peoples Hosp Cixi, Cixi, Peoples R China
基金
中国国家自然科学基金;
关键词
Antimicrobial resistance; enterococci; linezolid; molecular epidemiology; nosocomial infection; phenicols; tedizolid; SEQUENCE TYPING SCHEME; FAECALIS; FAECIUM; ANTIBIOTICS; INFECTIONS; PHENICOLS; CFR;
D O I
10.1016/j.cmi.2015.08.007
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
A collection of 1159 enterococcal isolates from five Chinese hospitals were screened for the presence of the novel oxazolidinone resistance gene optrA, which was found in 34 (2.9%) isolates. Pulsed-field gel electrophoresis (PFGE) typing of 29 optrA-carrying Enterococcus faecalis isolates revealed 25 PFGE patterns, and multilocus sequence typing yielded 20 sequence types. Routine surveillance of optrA-positive enterococci in hospitals should be conducted to monitor and counteract their further dissemination. The data of this study may be used as a baseline from which to judge future decreases or increases in optrA-positive enterococci. Clinical Microbiology and Infection (C) 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:1095.e1 / 1095.e4
页数:4
相关论文
共 15 条
[1]  
[Anonymous], 2015, PERF STAND ANT SUSC
[2]   Comparative In Vitro Antimicrobial Activities of Torezolid (TR-700), the Active Moiety of a New Oxazolidinone, Torezolid Phosphate (TR-701), Determination of Tentative Disk Diffusion Interpretive Criteria, and Quality Control Ranges [J].
Brown, Steven D. ;
Traczewski, Maria M. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (05) :2063-2069
[3]  
Clinical Laboratory Standards Institute, 2015, METH DIL ANT SUSC TE, V9th
[4]   Multilocus sequence typing scheme for Enterococcus faecium [J].
Homan, WL ;
Tribe, D ;
Poznanski, S ;
Li, M ;
Hogg, G ;
Spalburg, E ;
van Embden, JDA ;
Willems, RJL .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (06) :1963-1971
[5]   FDA Guidance for ABSSSI Trials: Implications for Conducting and Interpreting Clinical Trials [J].
Itani, Kamal M. F. ;
Shorr, Andrew F. .
CLINICAL INFECTIOUS DISEASES, 2014, 58 :S4-S9
[6]   Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit [J].
Johnson, AP ;
Tysall, L ;
Stockdale, MW ;
Woodford, N ;
Kaufmann, ME ;
Warner, M ;
Livermore, DM ;
Asboth, F ;
Allerberger, FJ .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (10) :751-754
[7]   Tedizolid for the Management of Human Infections: In Vitro Characteristics [J].
Locke, Jeffrey B. ;
Zurenko, Gary E. ;
Shaw, Karen Joy ;
Bartizal, Kenneth .
CLINICAL INFECTIOUS DISEASES, 2014, 58 :S35-S42
[8]   The Cfr rRNA methyltransferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins, and streptograrnin A antibiotics [J].
Long, Katherine S. ;
Poehlsgaard, Jacob ;
Kehrenberg, Corinna ;
Schwarz, Stefan ;
Vester, Birte .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) :2500-2505
[9]   Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms [J].
Mendes, Rodrigo E. ;
Deshpande, Lalitagauri M. ;
Jones, Ronald N. .
DRUG RESISTANCE UPDATES, 2014, 17 (1-2) :1-12
[10]   Tedizolid: A Novel Oxazolidinone for Gram-Positive Infections [J].
Moellering, Robert C., Jr. .
CLINICAL INFECTIOUS DISEASES, 2014, 58 :S1-S3